Part IV - Recovery
Published online by Cambridge University Press: 07 October 2023
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- The Opioid EpidemicOrigins, Current State and Potential Solutions, pp. 163 - 217Publisher: Cambridge University PressPrint publication year: 2023
References
References and Further Reading
Clark, RE, Baxter, JD, Aweh, G, et al. (2015). Risk factors for relapse and higher costs among Medicaid members with opioid dependence or abuse: Opioid agonists, comorbidities, and treatment history. Journal of Substance Abuse Treatment 57: 75–80.CrossRefGoogle ScholarPubMed
DiClemente, CC, Holmgren, MA, Rounsaville, D (2010). Relapse prevention and recycling in addiction. In Johnson, B (ed.) Addiction Medicine. Springer, New York, NY.Google Scholar
Douaihy, A, Daley, D, Marlatt, A, Donovan, DM (2014). Relapse prevention: Clinical models and intervention strategies. In Ries, RK, DA, Fiellin, SC, Miller, Saitz, R (eds.) The ASAM Principles of Addiction Medicine, 5th ed. Philadelphia, PA: Wolters Kluwer, pp. 553–565.Google Scholar
Kakko, J, Alho, H, Baldacchino, A, et al. (2019). Craving in opioid use disorder: From neurobiology to clinical practice. Frontiers in Psychiatry 30(10): 592.Google Scholar
Kelly, JF, Greene, MG, Bergman, BG, White, WL Hoeppner, BB (2019). How many recovery attempts does it take to successfully resolve an alcohol or drug problem? Estimates and correlates from a national study of recovering U.S. adults. Alcohol Clinical and Experimental Research 43(7): 1533–1544.CrossRefGoogle ScholarPubMed
Larimer, ME, Palmer, RS, Marlatt, GA (1999). Relapse prevention: An overview of Marlatt’s cognitive–behavioral model. Alcohol Research and Health 23(2): 151–160.Google ScholarPubMed
Melemis, SM (2015). Relapse prevention and the five rules of recovery. Yale Journal of Biology and Medicine 88: 325–32.Google Scholar
Menon, J, Kandasamy, A (2018). Relapse prevention. Indian Journal of Psychiatry 60(Suppl 4): S473–8.Google ScholarPubMed
Smelson, DA, Kline, A, Marzilli, A, Tripp, J (n.d.). The MISSION Consumer Workbook. www.umassmed.edu/contentassets/58c9d438c9ef4f7f8a4a44e9452d471a/mission-consumer-workbook.pdf.Google Scholar
Smyth, BP, Barry, J, Keenan, E, Ducray, K (2010). Lapse and relapse following inpatient treatment of opiate dependence. Irish Medical Journal 103(6): 176–179.Google Scholar
References and Further Reading
Balonon-Rosen, P (2019). From cringeworthy to scary: A history of anti-drug PSAs. www.marketplace.org/2019/03/26/advertisings-war-drugs-also-failed.Google Scholar
Bryson, EO (2012). Addicted Healers: 5 Key Signs your Healthcare Professional May Be Drug Impaired. Summit, NJ: New Horizon Press.Google Scholar
Dufton, E (2014). The acid rescue squad: Drug education and prevention in the 1960s and ‘70s. https://pointshistory.com/2014/05/09/the-acid-rescue-squad-drug-education-and-prevention-in-the-1960s-and-70s.Google Scholar
Dufton, E (2017). Grass Roots: The Rise and Fall and Rise of Marijuana in America. Toledo, OH: Discover Books.Google Scholar
DuPont, RL, McLellan, AT, White, WL, Merlo, LJ, Gold, MS (2009a). Setting the standard for recovery: Physicians’ health programs. Journal of Substance Abuse Treatment 36(2): 159–171.CrossRefGoogle ScholarPubMed
DuPont, RL, McLellan, AT, Carr, G, Gendel, M, Skipper, GE (2009b). How are addicted physicians treated? A national survey of physician health programs. Journal of Substance Abuse Treatment 37(1): 1–7.Google Scholar
Harrison, PA, Asche, SE (1999). Comparison of substance abuse treatment outcomes for inpatients and outpatients. Journal of Substance Abuse Treatment 17(3): 207–220.CrossRefGoogle ScholarPubMed
Ingraham, C (2017). A brief history of DARE, the anti-drug program Jeff Sessions wants to revive. Washington Post, July 12. www.washingtonpost.com/news/wonk/wp/2017/07/12/a-brief-history-of-d-a-r-e-the-anti-drug-program-jeff-sessions-wants-to-revive.Google Scholar
Malivert, M, Fatséas, M, Denis, C, Langlois, E, Auriacombe, M (2012). Effectiveness of therapeutic communities: A systematic review. European Addiction Research 18(1): 1–11.Google Scholar
McLellan, AT, Skipper, GS, Campbell, M, DuPont, RL (2008). Five-year outcomes in a cohort study of physicians treated for substance use disorders in the United States. British Medical Journal 337: a2038.Google Scholar
McLellan, AT, Koob, GF, Volkow, ND (2022). Preaddiction: A missing concept for treating substance use disorders. JAMA Psychiatry 79(8): 749–751.CrossRefGoogle ScholarPubMed
Monroe, T, Pearson, F, Kenaga, H (2008). Procedures for handling cases of substance abuse among nurses: A comparison of disciplinary and alternative programs. Journal of Addictions Nursing 19: 156–161.Google Scholar
NIDA (1980). Marijuana research findings: 1980. NIDA Research Monograph. https://archives.nida.nih.gov/sites/default/files/monograph31.pdf.Google Scholar
Oudejans, SC, Schippers, GM, Spits, ME, Stollenga, M, van den Brink, W (2012). Five years of ROM in substance abuse treatment centres in the Netherlands. Tijdschrift voor Psychiatrie 54(2): 185–190.Google Scholar
PBS Frontline (2000). Interview with Dr. Robert DuPont. www.pbs.org/wgbh/pages/frontline/shows/drugs/interviews/dupont.html.Google Scholar
Talbott, GD, Gallegos, KV, Wilson, PO, Porter, TL (1987). The Medical Association of Georgia’s Impaired Physicians Program Review of the first 1,000 physicians: Analysis of specialty. JAMA 257: 2927–30.Google Scholar
WBTV 3 (2010). Elementary student brings pot to school to turn in his parents. www.wbtv.com/story/13330034/couple-facing-drug-charges-after-child-tips-off-cop-at-school/.Google Scholar
Anti-Cocaine public service announcment from 1988: www.youtube.com/watch?v=IzWdTk-2fAY.Google Scholar
Anti-Marijuana public service announcment from 2001: www.youtube.com/watch?v=2lchxh9AOh8.Google Scholar
References and Further Reading
Brody, GH, Kogan, SM, Chen, Y, McBride Murry, V (2008). Long-term effects of the Strong African American Families Program on youths’ conduct problems. Journal of Adolescent Health 43: 474–481.CrossRefGoogle ScholarPubMed
Champion, KE, Newton, NC, Teeson, M (2021). Prevention of substance use disorders. In Textbook of Substance Use Disorder Treatment, 6th ed. Washington, DC: APA Publishing, ch. 35.Google Scholar
Dowell, D, Ragan, KR, Jones, CM, Baldwin, GT, Chou, R (2022). CDC Clinical Practice Guideline for prescribing opioids for pain – United States, 2022. Morbidity and Mortality Weekly Report 71: 1–95. www.cdc.gov/mmwr/volumes/71/rr/rr7103a1.htm#B1_down.Google ScholarPubMed
Drug Policy Alliance (2022). A history of the Drug War. https://drugpolicy.org/issues/brief-history-drug-war.Google Scholar
Gaetz, S (2014). Can housing first work for youth? European Journal of Homelessness 8(2): 159–175.Google Scholar
Hodge, JG, Gostin, LO (2019). Guiding industry settlements of opioid litigation. American Journal of Drug and Alcohol Abuse 45(5): 432–437.CrossRefGoogle ScholarPubMed
Kellam, SG., Mackenzie, ACL, Brown, CH, et al. (2011). The Good Behavior Game and the future of prevention and treatment. Addiction Science & Clinical Practice 6(1): 73–84.Google ScholarPubMed
Klimas, J, Gorfinkel, L, Fairbairn, N, et al. (2019). Strategies to identify patient risks of prescription opioid addiction when initiative opioids for pain. JAMA Network Open 2(5): e193365.Google Scholar
Lee, N (2021). America has spent over a trillion dollars fighting the war on drugs; 50 years later, drug use in the U.S. is climbing again. www.cnbc.com/2021/06/17/the-us-has-spent-over-a-trillion-dollars-fighting-war-on-drugs.html.Google Scholar
Lipari, RN, Hughes, A (2017). How people obtain the prescription pain relievers they misuse. www.samhsa.gov/data/sites/default/files/report_2686/ShortReport-2686.html.Google Scholar
Livingston, CJ, Berenji, M, Titus, TM, et al. (2022). American College of Preventive Medicine: Addressing the opioid epidemic through a prevention framework. American Journal of Preventive Medicine 63(3): 454–465.CrossRefGoogle ScholarPubMed
Nelson, LF, Weitzman, ER, Levy, S (2021). Prevention of substance use disorders. Medical Clinics of North America http://harmsprogram.ca/ 106(1): 153–168.Google Scholar
Salwan, AJ, Hagemeier, NE, Harirforoosh, S (2018). Abuse-deterrent opioid formulations: A key ingredient in the recipe to prevent opioid disasters? Clinical Drug Investigation 38: 573–577.CrossRefGoogle ScholarPubMed
SAMHSA (2015). Module 3: primary prevention and the six strategies. www.samhsa.gov/grants/block-grants/sabg/primary-prevention-course.Google Scholar
SAMHSA (2019). Substance Misuse Prevention for Young Adults. Rockville, MD: National Mental Health and Substance Use Policy Laboratory. Substance Abuse and Mental Health Services Administration.Google Scholar
Thornton, C (2022). The U.S. had led the War on Drugs abroad for decades, and it’s been a staggering failure. New York Times, September 7. www.nytimes.com/2022/09/07/opinion/colombia-drug-war-us.htmlGoogle Scholar
United Nations Office on Drugs and Crime (2018). International Standards on Drug Use Prevention, 2nd ed. Vienna; United Nations Office on Drugs and Crime.Google Scholar
United States Department of Health and Human Services (HHS), Office of the Surgeon General (2016). Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs, and Health. Washington, DC: HHS.Google Scholar
US Library of Congress (2017–2018). Substance Use Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act. H.R. 6., 115th Congress (2017–2018). www.congress.gov/bill/115th-congress/house-bill/6.Google Scholar
US Preventive Services Task Force (2020). Screening for unhealthy drug use: US Preventive Services Task Force recommendation statement. JAMA 323(22): 2301–2309.Google Scholar
Washington State Institute for Public Policy (2019). Benefit–cost results. www.wsipp.wa.gov/BenefitCost?topicId=9.Google Scholar
References and Further Reading
Baltimore Sun (2017). Is Md. ready for ‘heroin assisted therapy’? Baltimore Sun, April 10.Google Scholar
Barnett, PG, Sorensen, JL, Wong, W, Haug, NA, Hall, SM (2009). Effect of incentives for medication adherence on health care use and costs in methadone patients with HIV. Drug Alcohol Depend 100(1–2):115–121.CrossRefGoogle ScholarPubMed
Guardian (2022). Canada to decriminalize some drugs in British Columbia for three years. Guardian, May 31. www.theguardian.com/world/2022/may/31/canada-decriminalize-drugs-british-columbia-overdoses.Google Scholar
Hiragaki, S, Suzuki, T, Mohamed, AAM, Takeda, M. (2015). Structures and functions of insect arylalkylamine Nacetyltransferase (iaaNAT): A key enzyme for physiological and behavioral switch in arthropods. Frontiers in Physiology 6: 113.Google Scholar
Laqueur, H (2015). Uses and abuses of drug decriminalization in Portugal. Law & Social Inquiry 40(3): 746–781.Google Scholar
Morris, J and Gillies, R (2022). Drug criminalization test OKed. San Francisco Chronicle, June 2, p. A2.Google Scholar
NIDA (2014). Principles of drug addiction treatment: A research-based guide (third edition). https://archives.nida.nih.gov/publications/principles-drug-addiction-treatment-research-based-guide-third-edition.Google Scholar
Oregon Health Authority (2021). Measure 110 Information for Individuals. www.oregon.gov/OHA/HSD/AMH/Docs/Measure-110-Individual-Fact-Sheet.pdf#:~:text=HEALTH%20SYSTEMS%20DIVISION%20Behavioral%20Health%20Programs%20Measure%20110,of%20getting%20arrested%2C%20people%20will%20get%20a%20citation.Google Scholar
Oregon State Government (2020). Drug Addiction Treatment and Recovery Act (Measure 110). www.oregon.gov/oha/hsd/amh/pages/measure110.aspx.Google Scholar
Oviedo-Joekes, E, Brissette, S, Marsh, DC, et al. (2009). Diacetylmorphine versus methadone for the treatment of opioid addiction. New England Journal of Medicine 361(8): 777–786.Google Scholar
Sordo, L, Barrio, G, Bravo, MJ, et al. (2017). Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.British Medical Journal 357: j1550.Google Scholar
Strang, J, Teodora Groshkova, T, Metrebian, N. (2012). EMCDDA Insights. New Heroin-Assisted Treatment: Recent Evidence and Current Practices of Supervised Injectable Heroin Treatment in Europe and Beyond. Lisbon: European Monitoring Center for Drugs and Addiction.Google Scholar
Strang, J, Groshkova, T, Uchtenhagen, A, et al. (2015). Heroin on trial: Systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction. British Journal of Psychiatry 207(1): 5–14.Google Scholar
van Staaden, MJ, Hall, FS, Huber, R. T (2018). The deep evolutionary roots of ‘addiction’. Journal of Mental Health and Clinical Psychology 2(3): 8–13.Google Scholar